In this article, PANews will explore Usual’s core potential and risks from perspectives such as its underlying operating logic and revenue distribution design.
In this article, PANews will explore Usual’s core potential and risks from perspectives such as its underlying operating logic and revenue distribution design.
MicroStrategy's stock has risen 402% this year, and Core Scientific has risen 307%; an anonymous user pledged 10,000 BTC on Babylon 10 days ago; VitaDAO plans to distribute 6.9 million BIO to VITA and VitaDAO IPT holders.